Inflammatory Bowel Disease (Surgical)

The surgical management of inflammatory bowel disease addresses Crohn's disease and ulcerative colitis when medical therapy fails or when complications arise. Although these are chronic conditions treated primarily with medication, a substantial proportion of patients ultimately require an operation. The surgical aims differ by disease: in ulcerative colitis surgery can be curative of the colonic disease, whereas in Crohn's disease, which can affect the whole gut, surgery is targeted at complications and segments of disease rather than cure.

Definition

Surgical inflammatory bowel disease refers to the operative management of Crohn's disease and ulcerative colitis, including resection of diseased bowel, treatment of complications such as stricture, fistula, abscess, and perforation, restorative proctocolectomy for ulcerative colitis, and surgery for medically refractory disease or neoplastic change.

Scope

This entry describes the role of surgery across inflammatory bowel disease, the contrasting surgical philosophies in ulcerative colitis and Crohn's disease, the principal operations such as restorative proctocolectomy with ileal pouch-anal anastomosis and limited resection for Crohn's, and the indications that bring patients to operation including failure of medical therapy, complications, and dysplasia. It is a reference description and does not provide treatment protocols or individualized advice.

Core questions

• How do the surgical goals differ between ulcerative colitis and Crohn's disease?
• What are the main indications for surgery in inflammatory bowel disease?
• What is restorative proctocolectomy with ileal pouch-anal anastomosis?
• When might earlier surgery be preferable to escalating medical therapy?

Key concepts

• Ulcerative colitis versus Crohn's disease
• Restorative proctocolectomy
• Ileal pouch-anal anastomosis
• Bowel-sparing resection
• Stricturoplasty
• Medically refractory disease
• Dysplasia and colorectal cancer risk
• Toxic megacolon

Mechanisms

Because ulcerative colitis is confined to the colon and rectum, removing the colon and rectum can eliminate the disease, and continuity is commonly restored by constructing a pouch from the terminal ileum joined to the anus (ileal pouch-anal anastomosis); the long-standing inflammation also raises colorectal cancer risk, so dysplasia is an indication for surgery (Ungaro et al., 2017). Crohn's disease can involve any part of the gut and tends to recur, so surgery aims to treat complications — stricture, fistula, abscess, perforation — while conserving bowel length, using limited resection or stricturoplasty rather than attempting cure; randomized evidence indicates that early laparoscopic ileocaecal resection is a reasonable alternative to escalating biologic therapy in limited terminal-ileal Crohn's disease (Ponsioen et al., 2017). Indications for operation across both diseases include failure or intolerance of medical therapy and acute complications such as toxic megacolon, and operative outcomes are graded by the Clavien-Dindo system (Clavien et al., 2009; Lamb et al., 2019).

Clinical relevance

Surgery is an integral part of the multidisciplinary care of inflammatory bowel disease, and understanding when and why an operation is undertaken is important for appreciating how surgical and medical treatment are coordinated over the long course of these diseases. This entry is educational and descriptive and is not a basis for individual diagnosis or treatment decisions.

Epidemiology

A considerable proportion of patients with inflammatory bowel disease undergo surgery during their lifetime, historically higher in Crohn's disease, which is prone to recurrence and complications; the introduction of biologic therapies has altered but not eliminated the need for surgery, and the relative timing of medical and surgical treatment remains an active question (Lamb et al., 2019; Ponsioen et al., 2017).

History

Surgery for inflammatory bowel disease evolved from total proctocolectomy with permanent ileostomy toward restorative procedures, notably the ileal pouch-anal anastomosis, which allowed continuity to be preserved after colectomy for ulcerative colitis. In Crohn's disease, recognition of the disease's recurrent, panenteric nature drove a shift from extensive resection toward bowel-sparing strategies. The arrival of biologic therapies reshaped the threshold for operation, and trials such as LIR!C have re-examined the place of early surgery relative to medical escalation.

Debates

Early surgery versus medical escalation in limited Crohn's disease

For limited terminal-ileal Crohn's disease, randomized evidence suggests laparoscopic ileocaecal resection is a reasonable alternative to starting or escalating biologic therapy, prompting debate over how early surgery should be offered relative to prolonged medical treatment.

Key figures

• Cyriel Ponsioen
• Ryan Ungaro

Seminal works

• ponsioen-2017
• lamb-2019

Frequently asked questions

Can surgery cure inflammatory bowel disease?

Surgery can remove the colonic disease of ulcerative colitis and is in that sense potentially curative for the colon, whereas Crohn's disease can recur anywhere in the gut, so surgery treats complications and segments of disease rather than curing it.

What is an ileal pouch-anal anastomosis?

It is an operation, often used after removing the colon and rectum for ulcerative colitis, in which a reservoir is constructed from the end of the small intestine and joined to the anus so that bowel continuity is preserved without a permanent stoma.